KENNETH M. FERGUSON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2022-04-26 Dr. Kenneth M. Ferguson ... Class 1 Director Nominee on behalf of our holders of Preferred Stock ... Dr. Ferguson has been nominated as Class 1 director, to represent the holders of the Preferred Stock ... Dr. Ferguson has no beneficial interest in any of our securities.
2023-11-14 Dr. Kenneth M. Ferguson(1) ... Includes options to purchase 2,637 shares of Common Stock ... and 7,911 Restricted Stock Units...
2024-05-08 Dr. Kenneth M. Ferguson ... Class 1 Director on behalf of our holders of Preferred Stock ... Compensation and Organization Development Committee currently has three members: Dr. Samuel L. Barker (Chairman), Dr. Christopher S. Henney and Dr. Kenneth M. Ferguson ... Science and Technology Committee ... consists of Dr. Robert J. Spiegel (Chairman), Dr. Samuel L. Barker, Dr. Kenneth M. Ferguson and Dr. Brian Schwartz

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04